Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/8091| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Poposka, Lidija | en_US |
| dc.date.accessioned | 2020-05-11T13:32:50Z | - |
| dc.date.available | 2020-05-11T13:32:50Z | - |
| dc.date.issued | 2013-07-15 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/8091 | - |
| dc.description.abstract | Novel oral anticoagulants are safer than Vitamin K antagonists (warfarin) in respect to the occurrence of bleeding, especially in terms of intracranial hemorrhage. Furthermore they are non-inferior and to a certain degree are superior in comparison to warfarin, when it comes to the prevention of ischemic stroke in patients with atrial fibrillation (AF). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | European Society of Cardiology | en_US |
| dc.relation.ispartof | e-Journal of Cardiology Practice | en_US |
| dc.subject | atrial fibrillation | en_US |
| dc.title | Novel anticoagulants in atrial fibrillation: focused update | en_US |
| dc.type | Article | en_US |
| dc.identifier.volume | 11 | - |
| dc.identifier.issue | 26 | - |
| item.fulltext | With Fulltext | - |
| item.grantfulltext | open | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Novel anticoagulants in atrial fibrillation focused update.pdf | 114.5 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.